Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial

Int J STD AIDS. 2019 Oct;30(12):1156-1162. doi: 10.1177/0956462419865829. Epub 2019 Sep 27.

Daniela Pellegrino¹, Ronaldo Gryschek^{2

3}, Augusto César Penalva de Oliveira⁴, Rosa Marcusso⁴, Ademir Correia⁵, José E Vidal^{2

4

6}

¹ Emergency Room, Institute of Infectious Diseases Emilio Ribas, São Paulo, Brazil.
² Division of Infectious and Parasitic Diseases, School of Medicine of the University of São Paulo, São Paulo, Brazil.
³ Section of Helminthology, Institute of Tropical Medicine of São Paulo, School of Medicine of the University of São Paulo, São Paulo, Brazil.
⁴ Department of Neurology, Institute of Infectious Diseases Emilio Ribas, São Paulo, Brazil.
⁵ Department of Radiology, Institute of Infectious Diseases Emilio Ribas, São Paulo, Brazil.
⁶ Medical Investigation Laboratory 49, Institute of Tropical Medicine of São Paulo, School of Medicine of the University of São Paulo, São Paulo, Brazil.

No abstract available

Keywords: Brazil; Cerebral toxoplasmosis; toxoplasmic encephalitis; treatment; trimethoprim-sulfamethoxazole.

Publication types